Recipients
EFSD / Johnson & Johnson Programme in Type 2 Diabetes



2004:

Torben Hansen - Steno Diabetes Center - Gentofte, Denmark
Indentification and characterisation of positional type 2 diabetes candidate genes localised on chromosome 8p22-p21

Stephan Herzig - German Cancer Research Centre - Heidelberg, Germany
Transcriptional control of insulin sensitivity through the repressor HES-1: implications for type 2 diabetes susceptibiliy

Allan Vaag - Steno Diabetes Center - Gentofte, Denmark
The impact of low birth weight for 24-hrs energy expenditure, in vivo insulin action and glucose metabolism, as well as gene and protein expression in muscle and adipose tissue, before and after overfeeding of a high-fat and energy rich diet among younger men

2003:

Johan Auwerx - IGBMC, - Illkirch, France
The role of PPARγ2, the adipose tissue specific PPARγ isoform, in metabolic control

Decio L. Eizirik - Université Libre - Brussels, Belgium
Molecular mechanisms of β-cell apoptosis induced by adipocyte-derived mediators in type 2 diabetes mellitus

Jens H. Nielsen - Copenhagen University - Copenhagen, Denmark
Stimulation of beta cell growth and function by GLP-1: the role of A kinase anchoring proteins (AKAPs) in differentiation, proliferation, survival and insulin secretion

2002:

Stefano Del Prato - Pisa University - Pisa, Italy
Role of insulin signalling pathways in the function and survival of human pancreatic islets

Marc Donath - Zurich University Hospital - Zurich, Switzerland
Mechanisms and modulation of glucose-induced Fas signalling in pancreatic β-cells

Pierre Maechler - Geneva University - Geneva, Switzerland
Overexpression and mutation analysis of glutamate dehydrogenase and its role in the regulation of insulin secretion from glucose and glutamine

Claes Wollheim - Geneva University - Geneva, Switzerland
Functional role of Pax4 in beta-cell proliferation and differentiation: potential implication in type 2 diabetes